ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Hereditary Angioedema - Global Market Insights and Sales Trends 2024
Published Date: December 2023
|
Report Code: QYRE-Auto-10D6662
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Hereditary Angioedema Market Insights Forecast to 2028
BUY CHAPTERS

Hereditary Angioedema - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-10D6662
Report
December 2023
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pharming Group NV
Takeda
CSL Limited
IBio Inc.
BioCryst Pharmaceuticals Inc
Ionis Pharmaceuticals Inc

Hereditary Angioedema - Market Size

The global Hereditary Angioedema market size is expected to reach US$ 2724.1 million by 2029, growing at a CAGR of 7.3% from 2023 to 2029.

Hereditary Angioedema - Market

Hereditary Angioedema - Market

Hereditary angioedema is a rare disease and is mostly mistaken for common allergic reactions and abdominal pain. This mainly on account of the lack of knowledge among both physicians and patients about the condition. About 40% of the affected patients are diagnosed correctly with hereditary angioedema in the US and Europe. With progress in diagnostic field and different initiatives undertaken by patient bodies and industry players to spread awareness, the market for hereditary angioedema is projected to grow.
The market is mainly driven by the significant applications of Hereditary Angioedema in various end use industries. The expanding demands from the Retail Pharmacies, Hospital Pharmacies and Online Pharmacies,, are propelling Hereditary Angioedema market. C1 Esterase Inhibitor, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Kallikrein Inhibitor segment is estimated at % CAGR for the next seven-year period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Distribution Channel. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hereditary Angioedema, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Hereditary Angioedema market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hereditary Angioedema market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hereditary Angioedema sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hereditary Angioedema covered in this report include Pharming Group NV, Takeda, CSL Limited, iBio Inc., BioCryst Pharmaceuticals, Inc. and Ionis Pharmaceuticals, Inc., etc.
The global Hereditary Angioedema market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pharming Group NV
Takeda
CSL Limited
iBio Inc.
BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.

Scope of Hereditary Angioedema - Market Report

Report Metric Details
Report Name Hereditary Angioedema - Market
Forecasted market size in 2029 US$ 2724.1 million
CAGR 7.3%
Forecasted years 2023 - 2029
Global Hereditary Angioedema market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hereditary Angioedema market, Segment by Type:
  • C1 Esterase Inhibitor
  • Kallikrein Inhibitor
  • Selective Bradykinin B2 Receptor Antagonist
  • Global Hereditary Angioedema market, by Distribution Channel
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Two: Detailed analysis of Hereditary Angioedema manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Three: Sales, revenue of Hereditary Angioedema in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
  • Chapter Four: Introduces market segments by Distribution Channel, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
  • Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Analysis of sales channel, distributors and customers.
  • Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What is the Hereditary Angioedema - Market size in 2029?

Ans: The Hereditary Angioedema - Market size in 2029 will be US$ 2724.1 million.

What are the Type segmentation covered in the Hereditary Angioedema - Market report?

Ans: The Types covered in the Hereditary Angioedema - Market report are C1 Esterase Inhibitor, Kallikrein Inhibitor, Selective Bradykinin B2 Receptor Antagonist, Global Hereditary Angioedema market, by Distribution Channel, Retail Pharmacies, Hospital Pharmacies, Online Pharmacies

1 Hereditary Angioedema Market Overview
1.1 Hereditary Angioedema Product Overview
1.2 Hereditary Angioedema Market Segment by Type
1.2.1 C1 Esterase Inhibitor
1.2.2 Kallikrein Inhibitor
1.2.3 Selective Bradykinin B2 Receptor Antagonist
1.3 Global Hereditary Angioedema Market Size by Type
1.3.1 Global Hereditary Angioedema Market Size Overview by Type (2018-2029)
1.3.2 Global Hereditary Angioedema Historic Market Size Review by Type (2018-2023)
1.3.3 Global Hereditary Angioedema Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Hereditary Angioedema Sales Breakdown by Type (2018-2023)
1.4.2 Europe Hereditary Angioedema Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Hereditary Angioedema Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Hereditary Angioedema Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Hereditary Angioedema Sales Breakdown by Type (2018-2023)
2 Global Hereditary Angioedema Market Competition by Company
2.1 Global Top Players by Hereditary Angioedema Sales (2018-2023)
2.2 Global Top Players by Hereditary Angioedema Revenue (2018-2023)
2.3 Global Top Players by Hereditary Angioedema Price (2018-2023)
2.4 Global Top Manufacturers Hereditary Angioedema Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hereditary Angioedema Market Competitive Situation and Trends
2.5.1 Hereditary Angioedema Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Hereditary Angioedema Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hereditary Angioedema as of 2022)
2.7 Date of Key Manufacturers Enter into Hereditary Angioedema Market
2.8 Key Manufacturers Hereditary Angioedema Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Hereditary Angioedema Status and Outlook by Region
3.1 Global Hereditary Angioedema Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Hereditary Angioedema Historic Market Size by Region
3.2.1 Global Hereditary Angioedema Sales in Volume by Region (2018-2023)
3.2.2 Global Hereditary Angioedema Sales in Value by Region (2018-2023)
3.2.3 Global Hereditary Angioedema Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Hereditary Angioedema Forecasted Market Size by Region
3.3.1 Global Hereditary Angioedema Sales in Volume by Region (2024-2029)
3.3.2 Global Hereditary Angioedema Sales in Value by Region (2024-2029)
3.3.3 Global Hereditary Angioedema Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Hereditary Angioedema by Distribution Channel
4.1 Hereditary Angioedema Market Segment by Distribution Channel
4.1.1 Retail Pharmacies
4.1.2 Hospital Pharmacies
4.1.3 Online Pharmacies
4.2 Global Hereditary Angioedema Market Size by Distribution Channel
4.2.1 Global Hereditary Angioedema Market Size Overview by Distribution Channel (2018-2029)
4.2.2 Global Hereditary Angioedema Historic Market Size Review by Distribution Channel (2018-2023)
4.2.3 Global Hereditary Angioedema Forecasted Market Size by Distribution Channel (2024-2029)
4.3 Key Regions Market Size Segment by Distribution Channel
4.3.1 North America Hereditary Angioedema Sales Breakdown by Distribution Channel (2018-2023)
4.3.2 Europe Hereditary Angioedema Sales Breakdown by Distribution Channel (2018-2023)
4.3.3 Asia-Pacific Hereditary Angioedema Sales Breakdown by Distribution Channel (2018-2023)
4.3.4 Latin America Hereditary Angioedema Sales Breakdown by Distribution Channel (2018-2023)
4.3.5 Middle East and Africa Hereditary Angioedema Sales Breakdown by Distribution Channel (2018-2023)
5 North America Hereditary Angioedema by Country
5.1 North America Hereditary Angioedema Historic Market Size by Country
5.1.1 North America Hereditary Angioedema Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Hereditary Angioedema Sales in Volume by Country (2018-2023)
5.1.3 North America Hereditary Angioedema Sales in Value by Country (2018-2023)
5.2 North America Hereditary Angioedema Forecasted Market Size by Country
5.2.1 North America Hereditary Angioedema Sales in Volume by Country (2024-2029)
5.2.2 North America Hereditary Angioedema Sales in Value by Country (2024-2029)
6 Europe Hereditary Angioedema by Country
6.1 Europe Hereditary Angioedema Historic Market Size by Country
6.1.1 Europe Hereditary Angioedema Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Hereditary Angioedema Sales in Volume by Country (2018-2023)
6.1.3 Europe Hereditary Angioedema Sales in Value by Country (2018-2023)
6.2 Europe Hereditary Angioedema Forecasted Market Size by Country
6.2.1 Europe Hereditary Angioedema Sales in Volume by Country (2024-2029)
6.2.2 Europe Hereditary Angioedema Sales in Value by Country (2024-2029)
7 Asia-Pacific Hereditary Angioedema by Region
7.1 Asia-Pacific Hereditary Angioedema Historic Market Size by Region
7.1.1 Asia-Pacific Hereditary Angioedema Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Hereditary Angioedema Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Hereditary Angioedema Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Hereditary Angioedema Forecasted Market Size by Region
7.2.1 Asia-Pacific Hereditary Angioedema Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Hereditary Angioedema Sales in Value by Region (2024-2029)
8 Latin America Hereditary Angioedema by Country
8.1 Latin America Hereditary Angioedema Historic Market Size by Country
8.1.1 Latin America Hereditary Angioedema Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Hereditary Angioedema Sales in Volume by Country (2018-2023)
8.1.3 Latin America Hereditary Angioedema Sales in Value by Country (2018-2023)
8.2 Latin America Hereditary Angioedema Forecasted Market Size by Country
8.2.1 Latin America Hereditary Angioedema Sales in Volume by Country (2024-2029)
8.2.2 Latin America Hereditary Angioedema Sales in Value by Country (2024-2029)
9 Middle East and Africa Hereditary Angioedema by Country
9.1 Middle East and Africa Hereditary Angioedema Historic Market Size by Country
9.1.1 Middle East and Africa Hereditary Angioedema Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Hereditary Angioedema Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Hereditary Angioedema Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Hereditary Angioedema Forecasted Market Size by Country
9.2.1 Middle East and Africa Hereditary Angioedema Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Hereditary Angioedema Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pharming Group NV
10.1.1 Pharming Group NV Company Information
10.1.2 Pharming Group NV Introduction and Business Overview
10.1.3 Pharming Group NV Hereditary Angioedema Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pharming Group NV Hereditary Angioedema Products Offered
10.1.5 Pharming Group NV Recent Development
10.2 Takeda
10.2.1 Takeda Company Information
10.2.2 Takeda Introduction and Business Overview
10.2.3 Takeda Hereditary Angioedema Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Takeda Hereditary Angioedema Products Offered
10.2.5 Takeda Recent Development
10.3 CSL Limited
10.3.1 CSL Limited Company Information
10.3.2 CSL Limited Introduction and Business Overview
10.3.3 CSL Limited Hereditary Angioedema Sales, Revenue and Gross Margin (2018-2023)
10.3.4 CSL Limited Hereditary Angioedema Products Offered
10.3.5 CSL Limited Recent Development
10.4 iBio Inc.
10.4.1 iBio Inc. Company Information
10.4.2 iBio Inc. Introduction and Business Overview
10.4.3 iBio Inc. Hereditary Angioedema Sales, Revenue and Gross Margin (2018-2023)
10.4.4 iBio Inc. Hereditary Angioedema Products Offered
10.4.5 iBio Inc. Recent Development
10.5 BioCryst Pharmaceuticals, Inc.
10.5.1 BioCryst Pharmaceuticals, Inc. Company Information
10.5.2 BioCryst Pharmaceuticals, Inc. Introduction and Business Overview
10.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Sales, Revenue and Gross Margin (2018-2023)
10.5.4 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Products Offered
10.5.5 BioCryst Pharmaceuticals, Inc. Recent Development
10.6 Ionis Pharmaceuticals, Inc.
10.6.1 Ionis Pharmaceuticals, Inc. Company Information
10.6.2 Ionis Pharmaceuticals, Inc. Introduction and Business Overview
10.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Products Offered
10.6.5 Ionis Pharmaceuticals, Inc. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Hereditary Angioedema Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Hereditary Angioedema Industrial Chain Analysis
11.4 Hereditary Angioedema Market Dynamics
11.4.1 Hereditary Angioedema Industry Trends
11.4.2 Hereditary Angioedema Market Drivers
11.4.3 Hereditary Angioedema Market Challenges
11.4.4 Hereditary Angioedema Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Hereditary Angioedema Distributors
12.3 Hereditary Angioedema Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Pharming Group NV
Takeda
CSL Limited
IBio Inc.
BioCryst Pharmaceuticals Inc
Ionis Pharmaceuticals Inc
List of Tables
    Table 1. Major Company of C1 Esterase Inhibitor
    Table 2. Major Company of Kallikrein Inhibitor
    Table 3. Major Company of Selective Bradykinin B2 Receptor Antagonist
    Table 4. Global Hereditary Angioedema Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 5. Global Hereditary Angioedema Sales by Type (2018-2023) & (K Units)
    Table 6. Global Hereditary Angioedema Sales Market Share in Volume by Type (2018-2023)
    Table 7. Global Hereditary Angioedema Sales by Type (2018-2023) & (US& Million)
    Table 8. Global Hereditary Angioedema Market Share in Value by Type (2018-2023)
    Table 9. Global Hereditary Angioedema Price by Type (2018-2023) & (USD/Unit)
    Table 10. Global Hereditary Angioedema Sales by Type (2024-2029) & (K Units)
    Table 11. Global Hereditary Angioedema Sales Market Share in Volume by Type (2024-2029)
    Table 12. Global Hereditary Angioedema Sales by Type (2024-2029) & (US$ Million)
    Table 13. Global Hereditary Angioedema Sales Market Share in Value by Type (2024-2029)
    Table 14. Global Hereditary Angioedema Price by Type (2024-2029) & (USD/Unit)
    Table 15. North America Hereditary Angioedema Sales by Type (2018-2023) & (K Units)
    Table 16. North America Hereditary Angioedema Sales by Type (2018-2023) & (US$ Million)
    Table 17. Europe Hereditary Angioedema Sales (K Units) by Type (2018-2023)
    Table 18. Europe Hereditary Angioedema Sales by Type (2018-2023) & (US$ Million)
    Table 19. Asia-Pacific Hereditary Angioedema Sales (K Units) by Type (2018-2023)
    Table 20. Asia-Pacific Hereditary Angioedema Sales by Type (2018-2023) & (US$ Million)
    Table 21. Latin America Hereditary Angioedema Sales (K Units) by Type (2018-2023)
    Table 22. Latin America Hereditary Angioedema Sales by Type (2018-2023) & (US$ Million)
    Table 23. Middle East and Africa Hereditary Angioedema Sales (K Units) by Type (2018-2023)
    Table 24. Middle East and Africa Hereditary Angioedema Sales by Type (2018-2023) & (US$ Million)
    Table 25. Global Hereditary Angioedema Sales by Company (2018-2023) & (K Units)
    Table 26. Global Hereditary Angioedema Sales Share by Company (2018-2023)
    Table 27. Global Hereditary Angioedema Revenue by Company (2018-2023) & (US$ Million)
    Table 28. Global Hereditary Angioedema Revenue Share by Company (2018-2023)
    Table 29. Global Market Hereditary Angioedema Price by Company (2018-2023) & (USD/Unit)
    Table 30. Global Hereditary Angioedema Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 31. Global Hereditary Angioedema Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hereditary Angioedema as of 2022)
    Table 33. Date of Key Manufacturers Enter into Hereditary Angioedema Market
    Table 34. Key Manufacturers Hereditary Angioedema Product Type
    Table 35. Mergers & Acquisitions, Expansion Plans
    Table 36. Global Hereditary Angioedema Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 37. Global Hereditary Angioedema Sales by Region (2018-2023) & (K Units)
    Table 38. Global Hereditary Angioedema Sales Market Share in Volume by Region (2018-2023)
    Table 39. Global Hereditary Angioedema Sales by Region (2018-2023) & (US$ Million)
    Table 40. Global Hereditary Angioedema Sales Market Share in Value by Region (2018-2023)
    Table 41. Global Hereditary Angioedema Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 42. Global Hereditary Angioedema Sales by Region (2024-2029) & (K Units)
    Table 43. Global Hereditary Angioedema Sales Market Share in Volume by Region (2024-2029)
    Table 44. Global Hereditary Angioedema Sales by Region (2024-2029) & (US$ Million)
    Table 45. Global Hereditary Angioedema Sales Market Share in Value by Region (2024-2029)
    Table 46. Global Hereditary Angioedema Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
    Table 47. Global Hereditary Angioedema Sales by Distribution Channel: 2018 VS 2022 VS 2029 (US$ Million)
    Table 48. Global Hereditary Angioedema Sales by Distribution Channel (2018-2023) & (K Units)
    Table 49. Global Hereditary Angioedema Sales Market Share in Volume by Distribution Channel (2018-2023)
    Table 50. Global Hereditary Angioedema Sales by Distribution Channel (2018-2023) & (US$ Million)
    Table 51. Global Hereditary Angioedema Sales Market Share in Value by Distribution Channel (2018-2023)
    Table 52. Global Hereditary Angioedema Price by Distribution Channel (2018-2023) & (USD/Unit)
    Table 53. Global Hereditary Angioedema Sales by Distribution Channel (2024-2029) & (K Units)
    Table 54. Global Hereditary Angioedema Sales Market Share in Volume by Distribution Channel (2024-2029)
    Table 55. Global Hereditary Angioedema Sales by Distribution Channel (2024-2029) & (US$ Million)
    Table 56. Global Hereditary Angioedema Sales Market Share in Value by Distribution Channel (2024-2029)
    Table 57. Global Hereditary Angioedema Price by Distribution Channel (2024-2029) & (USD/Unit)
    Table 58. North America Hereditary Angioedema Sales by Distribution Channel (2018-2023) (K Units)
    Table 59. North America Hereditary Angioedema Sales by Distribution Channel (2018-2023) & (US$ Million)
    Table 60. Europe Hereditary Angioedema Sales by Distribution Channel (2018-2023) (K Units)
    Table 61. Europe Hereditary Angioedema Sales by Distribution Channel (2018-2023) & (US$ Million)
    Table 62. Asia-Pacific Hereditary Angioedema Sales by Distribution Channel (2018-2023) (K Units)
    Table 63. Asia-Pacific Hereditary Angioedema Sales by Distribution Channel (2018-2023) & (US$ Million)
    Table 64. Latin America Hereditary Angioedema Sales by Distribution Channel (2018-2023) (K Units)
    Table 65. Latin America Hereditary Angioedema Sales by Distribution Channel (2018-2023) & (US$ Million)
    Table 66. Middle East and Africa Hereditary Angioedema Sales by Distribution Channel (2018-2023) (K Units)
    Table 67. Middle East and Africa Hereditary Angioedema Sales by Distribution Channel (2018-2023) & (US$ Million)
    Table 68. North America Hereditary Angioedema Sales by Country (2018-2023) & (K Units)
    Table 69. North America Hereditary Angioedema Sales Market Share in Volume by Country (2018-2023)
    Table 70. North America Hereditary Angioedema Sales by Country (2018-2023) & (US$ Million)
    Table 71. North America Hereditary Angioedema Sales Market Share in Value by Country (2018-2023)
    Table 72. North America Hereditary Angioedema Sales by Country (2024-2029) & (K Units)
    Table 73. North America Hereditary Angioedema Sales Market Share in Volume by Country (2024-2029)
    Table 74. North America Hereditary Angioedema Sales by Country (2024-2029) & (US$ Million)
    Table 75. North America Hereditary Angioedema Sales Market Share in Value by Country (2024-2029)
    Table 76. Europe Hereditary Angioedema Sales by Country (2018-2023) & (K Units)
    Table 77. Europe Hereditary Angioedema Sales Market Share in Volume by Country (2018-2023)
    Table 78. Europe Hereditary Angioedema Sales by Country (2018-2023) & (US$ Million)
    Table 79. Europe Hereditary Angioedema Sales Market Share in Value by Country (2018-2023)
    Table 80. Europe Hereditary Angioedema Sales by Country (2024-2029) & (K Units)
    Table 81. Europe Hereditary Angioedema Sales Market Share in Volume by Country (2024-2029)
    Table 82. Europe Hereditary Angioedema Sales by Country (2024-2029) & (US$ Million)
    Table 83. Europe Hereditary Angioedema Sales Market Share in Value by Country (2024-2029)
    Table 84. Asia-Pacific Hereditary Angioedema Sales by Region (2018-2023) & (K Units)
    Table 85. Asia-Pacific Hereditary Angioedema Sales Market Share in Volume by Region (2018-2023)
    Table 86. Asia-Pacific Hereditary Angioedema Sales by Region (2018-2023) & (US$ Million)
    Table 87. Asia-Pacific Hereditary Angioedema Sales Market Share in Value by Region (2018-2023)
    Table 88. Asia-Pacific Hereditary Angioedema Sales by Region (2024-2029) & (K Units)
    Table 89. Asia-Pacific Hereditary Angioedema Sales Market Share in Volume by Region (2024-2029)
    Table 90. Asia-Pacific Hereditary Angioedema Sales by Region (2024-2029) & (US$ Million)
    Table 91. Asia-Pacific Hereditary Angioedema Sales Market Share in Value by Region (2024-2029)
    Table 92. Latin America Hereditary Angioedema Sales by Country (2018-2023) & (K Units)
    Table 93. Latin America Hereditary Angioedema Sales Market Share in Volume by Country (2018-2023)
    Table 94. Latin America Hereditary Angioedema Sales by Country (2018-2023) & (US$ Million)
    Table 95. Latin America Hereditary Angioedema Sales Market Share in Value by Country (2018-2023)
    Table 96. Latin America Hereditary Angioedema Sales by Country (2024-2029) & (K Units)
    Table 97. Latin America Hereditary Angioedema Sales Market Share in Volume by Country (2024-2029)
    Table 98. Latin America Hereditary Angioedema Sales by Country (2024-2029) & (US$ Million)
    Table 99. Latin America Hereditary Angioedema Sales Market Share in Value by Country (2024-2029)
    Table 100. Middle East and Africa Hereditary Angioedema Sales by Country (2018-2023) & (K Units)
    Table 101. Middle East and Africa Hereditary Angioedema Sales Market Share in Volume by Country (2018-2023)
    Table 102. Middle East and Africa Hereditary Angioedema Sales by Country (2018-2023) & (US$ Million)
    Table 103. Middle East and Africa Hereditary Angioedema Sales Market Share in Value by Country (2018-2023)
    Table 104. Middle East and Africa Hereditary Angioedema Sales by Country (2024-2029) & (K Units)
    Table 105. Middle East and Africa Hereditary Angioedema Sales Market Share in Volume by Country (2024-2029)
    Table 106. Middle East and Africa Hereditary Angioedema Sales by Country (2024-2029) & (US$ Million)
    Table 107. Middle East and Africa Hereditary Angioedema Sales Market Share in Value by Country (2024-2029)
    Table 108. Pharming Group NV Company Information
    Table 109. Pharming Group NV Introduction and Business Overview
    Table 110. Pharming Group NV Hereditary Angioedema Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 111. Pharming Group NV Hereditary Angioedema Product
    Table 112. Pharming Group NV Recent Development
    Table 113. Takeda Company Information
    Table 114. Takeda Introduction and Business Overview
    Table 115. Takeda Hereditary Angioedema Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 116. Takeda Hereditary Angioedema Product
    Table 117. Takeda Recent Development
    Table 118. CSL Limited Company Information
    Table 119. CSL Limited Introduction and Business Overview
    Table 120. CSL Limited Hereditary Angioedema Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 121. CSL Limited Hereditary Angioedema Product
    Table 122. CSL Limited Recent Development
    Table 123. iBio Inc. Company Information
    Table 124. iBio Inc. Introduction and Business Overview
    Table 125. iBio Inc. Hereditary Angioedema Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 126. iBio Inc. Hereditary Angioedema Product
    Table 127. iBio Inc. Recent Development
    Table 128. BioCryst Pharmaceuticals, Inc. Company Information
    Table 129. BioCryst Pharmaceuticals, Inc. Introduction and Business Overview
    Table 130. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 131. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Product
    Table 132. BioCryst Pharmaceuticals, Inc. Recent Development
    Table 133. Ionis Pharmaceuticals, Inc. Company Information
    Table 134. Ionis Pharmaceuticals, Inc. Introduction and Business Overview
    Table 135. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 136. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Product
    Table 137. Ionis Pharmaceuticals, Inc. Recent Development
    Table 138. Key Raw Materials Lists
    Table 139. Raw Materials Key Suppliers Lists
    Table 140. Hereditary Angioedema Market Trends
    Table 141. Hereditary Angioedema Market Drivers
    Table 142. Hereditary Angioedema Market Challenges
    Table 143. Hereditary Angioedema Market Restraints
    Table 144. Hereditary Angioedema Distributors List
    Table 145. Hereditary Angioedema Downstream Customers
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Hereditary Angioedema Product Picture
    Figure 2. Global Hereditary Angioedema Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Hereditary Angioedema Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Hereditary Angioedema Sales Status and Outlook (2018-2029) & (K Units)
    Figure 5. Product Picture of C1 Esterase Inhibitor
    Figure 6. Global C1 Esterase Inhibitor Sales YoY Growth (2018-2029) & (K Units)
    Figure 7. Product Picture of Kallikrein Inhibitor
    Figure 8. Global Kallikrein Inhibitor Sales YoY Growth (2018-2029) & (K Units)
    Figure 9. Product Picture of Selective Bradykinin B2 Receptor Antagonist
    Figure 10. Global Selective Bradykinin B2 Receptor Antagonist Sales YoY Growth (2018-2029) & (K Units)
    Figure 11. Global Hereditary Angioedema Sales by Type (2018-2029) & (US$ Million)
    Figure 12. Global Hereditary Angioedema Sales Market Share by Type in 2022 & 2029
    Figure 13. North America Hereditary Angioedema Sales Market Share in Volume by Type in 2022
    Figure 14. North America Hereditary Angioedema Sales Market Share in Value by Type in 2022
    Figure 15. Europe Hereditary Angioedema Sales Market Share in Volume by Type in 2022
    Figure 16. Europe Hereditary Angioedema Sales Market Share in Value by Type in 2022
    Figure 17. Asia-Pacific Hereditary Angioedema Sales Market Share in Volume by Type in 2022
    Figure 18. Asia-Pacific Hereditary Angioedema Sales Market Share in Value by Type in 2022
    Figure 19. Latin America Hereditary Angioedema Sales Market Share in Volume by Type in 2022
    Figure 20. Latin America Hereditary Angioedema Sales Market Share in Value by Type in 2022
    Figure 21. Middle East and Africa Hereditary Angioedema Sales Market Share in Volume by Type in 2022
    Figure 22. Middle East and Africa Hereditary Angioedema Sales Market Share in Value by Type in 2022
    Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Hereditary Angioedema Sales in 2022
    Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Hereditary Angioedema Revenue in 2022
    Figure 25. Hereditary Angioedema Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 26. Product Picture of Retail Pharmacies
    Figure 27. Global Retail Pharmacies Sales YoY Growth (2018-2029) & (K Units)
    Figure 28. Product Picture of Hospital Pharmacies
    Figure 29. Global Hospital Pharmacies Sales YoY Growth (2018-2029) & (K Units)
    Figure 30. Product Picture of Online Pharmacies
    Figure 31. Global Online Pharmacies Sales YoY Growth (2018-2029) & (K Units)
    Figure 32. Global Hereditary Angioedema Sales by Distribution Channel (2018-2029) & (US$ Million)
    Figure 33. Global Hereditary Angioedema Sales Market Share by Distribution Channel in 2022 & 2029
    Figure 34. North America Hereditary Angioedema Sales Market Share in Volume by Distribution Channel in 2022
    Figure 35. North America Hereditary Angioedema Sales Market Share in Value by Distribution Channel in 2022
    Figure 36. Europe Hereditary Angioedema Sales Market Share in Volume by Distribution Channel in 2022
    Figure 37. Europe Hereditary Angioedema Sales Market Share in Value by Distribution Channel in 2022
    Figure 38. Asia-Pacific Hereditary Angioedema Sales Market Share in Volume by Distribution Channel in 2022
    Figure 39. Asia-Pacific Hereditary Angioedema Sales Market Share in Value by Distribution Channel in 2022
    Figure 40. Latin America Hereditary Angioedema Sales Market Share in Volume by Distribution Channel in 2022
    Figure 41. Latin America Hereditary Angioedema Sales Market Share in Value by Distribution Channel in 2022
    Figure 42. Middle East and Africa Hereditary Angioedema Sales Market Share in Value by Distribution Channel in 2022
    Figure 43. Key Raw Materials Price
    Figure 44. Hereditary Angioedema Manufacturing Cost Structure
    Figure 45. Hereditary Angioedema Industrial Chain Analysis
    Figure 46. Channels of Distribution
    Figure 47. Distributors Profiles
    Figure 48. Bottom-up and Top-down Approaches for This Report
    Figure 49. Data Triangulation
    Figure 50. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions